| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.94M | 63.76M | 52.59M | 37.46M | 27.97M | 18.67M |
| Gross Profit | 33.41M | 32.66M | 33.89M | 33.06M | 24.04M | 13.16M |
| EBITDA | 1.23M | 3.52M | 7.30M | 8.93M | -4.21M | -928.00K |
| Net Income | 566.00K | 1.93M | 4.51M | 5.64M | -4.05M | -642.00K |
Balance Sheet | ||||||
| Total Assets | 1.23B | 1.30B | 1.38B | 1.18B | 1.09B | 483.38M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 146.32M | 422.14M | 344.85M | 387.92M | 106.81M |
| Total Debt | 133.00M | 262.14M | 396.79M | 205.81M | 151.91M | 113.81M |
| Total Liabilities | 941.64M | 1.02B | 1.09B | 904.64M | 952.40M | 434.49M |
| Stockholders Equity | 285.55M | 285.16M | 281.90M | 279.48M | 141.00M | 48.88M |
Cash Flow | ||||||
| Free Cash Flow | -1.13M | 1.25M | 7.39M | 6.00M | -514.00K | -13.97M |
| Operating Cash Flow | -1.07M | 1.39M | 7.59M | 6.32M | 624.00K | -13.55M |
| Investing Cash Flow | 53.84M | 28.22M | -100.04M | -323.96M | 25.02M | 50.71M |
| Financing Cash Flow | -126.78M | -73.45M | 181.54M | 102.22M | 109.82M | 43.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $82.37M | 10.51 | 10.86% | 2.21% | 6.17% | -6.13% | |
71 Outperform | $77.56M | 14.53 | 5.50% | 2.08% | 1.03% | -35.72% | |
69 Neutral | $82.80M | 10.89 | 10.91% | 6.51% | 6.31% | -5.00% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $92.73M | -11.75 | -4.68% | 2.86% | 8.02% | 21.36% | |
47 Neutral | $55.08M | -20.81 | 0.22% | ― | 2.54% | -174.74% | |
45 Neutral | $77.18M | -54.92 | -1.41% | ― | -0.81% | -129.22% |
On November 24, 2025, Broadway Financial Corporation announced that it received a notification from Nasdaq regarding its non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Q3 Form 10-Q for the quarter ended September 30, 2025. This delay was attributed to the evaluation of its sold loan participation accounting and its impact on the consolidated financial statements. Although the notice does not immediately affect the company’s listing or trading on Nasdaq, further delays could potentially impact its stock. The company has until December 8, 2025, to submit an updated compliance plan to Nasdaq, and if accepted, it may have until February 16, 2026, to regain compliance.
On October 15, 2025, Broadway Financial Corporation announced that its Audit Committee determined the company’s goodwill is impaired, leading to a non-cash $25.9 million goodwill impairment charge for the quarter ended September 30, 2025. This charge is not expected to result in future cash expenditures, indicating limited immediate financial impact on the company’s operations.